Healthcare

Orthopedic Regenerative Surgical Products Market Size to Rake US$ 10.2 billion by 2030

The global Orthopedic Regenerative Surgical Products market size was valued at US$ 5.4 billion in 2020 and is anticipated to grow at a CAGR of 8.6% during forecast period 2021 to 2030.

Orthopedic Regenerative Surgical Products Market (By Product: Allograft, Synthetic, Cell-based, Viscosupplements; By Application: Orthopedic Pain Management, Trauma Repair, Cartilage and Tendon Repair, Joint Reconstruction, Others; By End-user: Hospitals, Ambulatory Surgical Centers, Others (Orthopedic Specialty Centers, Clinics)) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38318

Market Insight

Report Coverage Details
Market Size US$ 10.2 billion by 2030
Growth Rate CAGR of 8.6% From 2021 to 2030
Base year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Product, Application, End-user
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Anika Therapeutics, Inc., Vericel Corporation, Baxter, Zimmer Biomet, Stryker, Smith+Nephew, AlloSource, Amniox Medical, Inc., VSY Biotechnology, Aptissen S.A, MiMedx

Report Highlights

The viscosupplements segment dominated the market for orthopedic regenerative surgical products and accounted for the largest revenue share of 52.7% in 2020. This growth is owing to rising incidence of knee pain and osteoarthritis. Factors such as aging, obesity, excessive exercise, external injury, and genetic predisposition, further contribute to knee osteoarthritis, thus driving the market for orthopedic regenerative surgical products. In December 2019, Fidia Pharma USA Inc. for instance, launched Hyaluronic Acid-based viscosupplement- Triluron, in the U.S. for treating pain in osteoarthritic patients. Seikagaku Corporation, on the other hand, launched an intra-articular viscosupplement injection- HyLink in March 2019, in Italy. The product is CE marked and provides pain relief for 26 weeks in knee osteoarthritis patients.

The joint reconstruction segment dominated the market for orthopedic regenerative surgical products and accounted for the largest revenue share of 45.0% in 2020. The key factors attributing to this share include increasing surgical procedures, adoption of regenerative solutions in joint reconstruction, and technological advancements.  Amniox Medical, Inc. for instance, offers its Clarix line of surgical allografts for use in orthopedic surgery in various procedures such as trauma and reconstruction, arthroplasty, and soft-tissue repair.

The hospitals segment dominated the market for orthopedic regenerative surgical products and accounted for the largest revenue share of 60.4% in 2020. The factors contributing to the large share of the segment include a higher volume of orthopedic procedures performed in hospital settings. The Gelenk Klinik orthopedic hospital in Germany for example, performs around 2400 surgical procedures every year and treats over 24,000 orthopedic patients annually.

The others segment comprising of orthopedic specialty centers and clinics is estimated to register the highest CAGR of 8.7% over the forecast period. This is owing to the high usage of orthopedic regenerative surgical products for pain management and other treatments within orthopedic clinics and centers.

North America dominated the orthopedic regenerative surgical products market and held the largest revenue share of 50.0% in 2020. This can be attributed to the presence of key players, an aging population, and technologically advanced healthcare facilities in the U.S. and Canada.

Key Players

  • Anika Therapeutics, Inc.
  • Vericel Corporation
  • Baxter
  • Zimmer Biomet
  • Stryker
  • Smith+Nephew
  • AlloSource
  • Amniox Medical, Inc.
  • VSY Biotechnology
  • Aptissen S.A
  • MiMedx

Market Segmentation

  • Product Outlook
    • Allograft
      • Amniotic Products
      • Others
    • Synthetic
    • Cell-based
    • Viscosupplements
  • Application Outlook
    • Orthopedic Pain Management
    • Trauma Repair
    • Cartilage and Tendon Repair
    • Joint Reconstruction
    • Others
  • End-user Outlook
    • Hospitals
    • Ambulatory Surgical Centers
    • Others (Orthopedic Specialty Centers, Clinics)
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • India
      • Japan
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38318

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Application Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Orthopedic Regenerative Surgical Products Market, By Product

7.1.  Orthopedic Regenerative Surgical Products Market, by Product, 2021-2030

7.1.1.    Allograft

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Synthetic

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Cell-based

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Viscosupplements

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Orthopedic Regenerative Surgical Products Market, By Application

8.1.  Orthopedic Regenerative Surgical Products Market, by Application, 2021-2030

8.1.1.    Orthopedic Pain Management

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Trauma Repair

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Cartilage and Tendon Repair

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Joint Reconstruction

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Orthopedic Regenerative Surgical Products Market, By End User

9.1.  Orthopedic Regenerative Surgical Products Market, by End User, 2021-2030

9.1.1.    Hospitals

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Ambulatory Surgical Centers

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Others (Orthopedic Specialty Centers, Clinics)

9.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Orthopedic Regenerative Surgical Products Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Product (2016-2030)

10.1.2.  Market Revenue and Forecast, by Application (2016-2030)

10.1.3.  Market Revenue and Forecast, by End User (2016-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.1.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.1.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.1.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Product (2016-2030)

10.2.2.  Market Revenue and Forecast, by Application (2016-2030)

10.2.3.  Market Revenue and Forecast, by End User (2016-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.2.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.2.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Product (2016-2030)

10.3.2.  Market Revenue and Forecast, by Application (2016-2030)

10.3.3.  Market Revenue and Forecast, by End User (2016-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.3.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.3.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Product (2016-2030)

10.4.2.  Market Revenue and Forecast, by Application (2016-2030)

10.4.3.  Market Revenue and Forecast, by End User (2016-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.5.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.6.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.6.3.      Market Revenue and Forecast, by End User (2016-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Product (2016-2030)

10.4.7.2.      Market Revenue and Forecast, by Application (2016-2030)

10.4.7.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Product (2016-2030)

10.5.2.  Market Revenue and Forecast, by Application (2016-2030)

10.5.3.  Market Revenue and Forecast, by End User (2016-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Product (2016-2030)

10.5.4.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.4.3.      Market Revenue and Forecast, by End User (2016-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Product (2016-2030)

10.5.5.2.      Market Revenue and Forecast, by Application (2016-2030)

10.5.5.3.      Market Revenue and Forecast, by End User (2016-2030)

Chapter 11.  Company Profiles

11.1.              Vericel Corporation

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Baxter

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Zimmer Biomet

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Stryker

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              Smith+Nephew

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              AlloSource

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Amniox Medical, Inc.

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              VSY Biotechnology

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Aptissen S.A

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           MiMedx

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38318

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button